K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 333.8 INR 1.46% Market Closed
Market Cap: 5.4B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

25.5
Current
21.1
Median
13.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
25.5
=
Enterprise Value
5B INR
/
EBITDA
195.7m INR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
13.2
2-Years Forward
EV/EBITDA
10
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More